Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 67
Filter
1.
Nat Commun ; 15(1): 5925, 2024 Jul 15.
Article in English | MEDLINE | ID: mdl-39009625

ABSTRACT

Van der Waals (vdW) stacking is a powerful technique to achieve desired properties in condensed matter systems through layer-by-layer crystal engineering. A remarkable example is the control over the twist angle between artificially-stacked vdW crystals, enabling the realization of unconventional phenomena in moiré structures ranging from superconductivity to strongly correlated magnetism. Here, we report the appearance of unusual 120° twisted faults in vdW magnet CrI3 crystals. In exfoliated samples, we observe vertical twisted domains with a thickness below 10 nm. The size and distribution of twisted domains strongly depend on the sample preparation methods, with as-synthesized unexfoliated samples showing tenfold thicker domains than exfoliated samples. Cooling induces changes in the relative populations among different twisting domains, rather than the previously assumed structural phase transition to the rhombohedral stacking. The stacking disorder induced by sample fabrication processes may explain the unresolved thickness-dependent magnetic coupling observed in CrI3.

2.
Travel Med Infect Dis ; 60: 102726, 2024 May 15.
Article in English | MEDLINE | ID: mdl-38754529

ABSTRACT

BACKGROUND: This study aims to describe post-chikungunya complications chronically developed cases in returning travelers from some epidemic/endemic regions, and the variables that are associated with the progression of acute or subacute cases to the chronic phase. METHODS: This single-center retrospective cohort study included chikungunya fever cases treated at La Paz-Carlos III University Hospital in Madrid, Spain, April 2014 to September 2016, when the chikungunya outbreak in Latin America started through the time of its greatest impact. RESULTS: The analysis included 119 cases. Of these, 67.2 % were male, with a median age of 41.0 years [IQR 16.0 to 76.0] years. Only 25.6 % of the patients attended a pre-travel advice consultation. Most patients reported arthralgias, which significantly impacted their daily quality of life (86 %). The mean duration of joint symptoms was 129.4 days, with a median of 90 days [IQR 0 to 715]. Factors found to be associated with chronic arthralgia include female sex, country of infection, age at diagnosis, previous diseases, symptoms during the acute phase, pain in previously injured tendons/joints, acute phase severity, and various laboratory markers such as hemoglobin, hematocrit, total serum bilirubin, and creatinine. Progression to chronic arthralgia significantly increased the need for changes in daily activity. Furthermore, 42.6 % of patients with chronic arthralgia reported recurrence of symptoms once they felt they had disappeared. Targeted treatment regimens led to significant improvements in these patients. CONCLUSIONS: The results of this study underscore the need for: (1) comprehensive pre-travel advice; (2) effective management of patients in specialized units, alongside early diagnosis and treatment, to prevent trivialization of these viral infections; and (3) the development of interdisciplinary recommendations to assist physicians in treating patients and enhancing outcomes.

5.
Travel Med Infect Dis ; 59: 102708, 2024.
Article in English | MEDLINE | ID: mdl-38467231

ABSTRACT

INTRODUCTION: Detecting imported diseases by migrants and individuals visiting friends and relatives (VFR) is key in the prevention and management of emergent infectious diseases acquired abroad. METHODS: Retrospective descriptive study on migrants and VFR from Central and South America between 2017 and 2022 attended at a National Referral Centre for Tropical Diseases in Madrid, Spain. Demographic characteristics, syndromes and confirmed travel-related diagnoses were obtained from hospital patient medical records. RESULTS: 1654 cases were registered, median age of 42 years, 69.1% were female, and 55.2% were migrants. Most cases came from Bolivia (49.6%), followed by Ecuador (12.9%). Health screening while asymptomatic (31.6%) was the main reason for consultation, followed by Chagas disease follow-up (31%). Of those asymptomatic at screening, 47,2% were finally diagnosed of any disease, mainly Chagas disease (19,7%) and strongyloidiasis (10,2%) CONCLUSION: Our study emphasizes the importance of proactive health screening to detect asymptomatic conditions in migrants and VFR, enabling timely intervention and improved health outcomes. By understanding the unique health profiles of immigrant populations, targeted public health interventions can be devised to safeguard the well-being of these vulnerable groups.


Subject(s)
Communicable Diseases, Imported , Transients and Migrants , Humans , Retrospective Studies , Female , Male , Adult , Communicable Diseases, Imported/epidemiology , Communicable Diseases, Imported/prevention & control , Communicable Diseases, Imported/diagnosis , Spain/epidemiology , Transients and Migrants/statistics & numerical data , Middle Aged , Travel/statistics & numerical data , Adolescent , Latin America/epidemiology , Latin America/ethnology , Young Adult , Chagas Disease/diagnosis , Chagas Disease/epidemiology , Chagas Disease/prevention & control , Child , Aged , Tropical Medicine , Referral and Consultation/statistics & numerical data , Emigrants and Immigrants/statistics & numerical data
6.
Front Hum Neurosci ; 18: 1201574, 2024.
Article in English | MEDLINE | ID: mdl-38487104

ABSTRACT

Introduction: This study focuses on broadening the applicability of the metaheuristic L1-norm fitted and penalized (L1L1) optimization method in finding a current pattern for multichannel transcranial electrical stimulation (tES). The metaheuristic L1L1 optimization framework defines the tES montage via linear programming by maximizing or minimizing an objective function with respect to a pair of hyperparameters. Methods: In this study, we explore the computational performance and reliability of different optimization packages, algorithms, and search methods in combination with the L1L1 method. The solvers from Matlab R2020b, MOSEK 9.0, Gurobi Optimizer, CVX's SeDuMi 1.3.5, and SDPT3 4.0 were employed to produce feasible results through different linear programming techniques, including Interior-Point (IP), Primal-Simplex (PS), and Dual-Simplex (DS) methods. To solve the metaheuristic optimization task of L1L1, we implement an exhaustive and recursive search along with a well-known heuristic direct search as a reference algorithm. Results: Based on our results, and the given optimization task, Gurobi's IP was, overall, the preferable choice among Interior-Point while MOSEK's PS and DS packages were in the case of Simplex methods. These methods provided substantial computational time efficiency for solving the L1L1 method regardless of the applied search method. Discussion: While the best-performing solvers show that the L1L1 method is suitable for maximizing either focality and intensity, a few of these solvers could not find a bipolar configuration. Part of the discrepancies between these methods can be explained by a different sensitivity with respect to parameter variation or the resolution of the lattice provided.

9.
Article in Spanish | IBECS | ID: ibc-228364

ABSTRACT

La viruela del mono es una zoonosis que se contagia principalmente a través del contacto directo con los fluidos y las lesiones cutáneas de personas contagiadas con vesículas aun activas. Aunque el virus fue aislado por primera vez en 1958, y el primer caso humano se identificó en un niño en 1970, en la República Democrática del Congo, la enfermedad ha aumentado progresivamente su incidencia en África, alcanzando en mayo de 2022 transmisión sostenida fuera de este continente. Al ser un virus de nueva introducción en nuestro entorno sanitario, es necesario aprender el patrón epidemiológico en un medio diferente al de las zonas tradicionalmente endémicas y conocer los tratamientos antivirales a nuestro alcance, así como las medidas profilácticas que podrían plantearse, sabiendo que como virus emergente en nuestras regiones las evidencias científicas aun son limitadas. Existen antivirales que han demostrado en modelos animales combatir eficazmente la enfermedad con muy buena tolerancia clínica. Esta enfermedad también ha obligado a revisar las características de las vacunas frente a la viruela, ya que han demostrado un efecto protector frente a la viruela del mono. Por ello, es importante disponer de un documento que recopile toda la información científica publicada a este respecto.(AU)


Monkeypox is a zoonosis that is spread mainly through direct contact with fluids and skin lesions of infected people with vesicles still active. Although the virus was isolated for the first time in 1958 and the first human case was identified in a child in 1970, in the Democratic Republic of the Congo, the disease has progressively increased its incidence in Africa reaching in May 2022 sustained transmission outside this continent. As it is a newly introduced virus in our health system, it is necessary to learn the epidemiological pattern in a different environment from that of traditionally endemic areas and to know the available antiviral treatments, as well as the prophylactic measures that could be considered, knowing that as a virus emerging in our regions, scientific evidence is still limited. There are antivirals that have been shown, in animal models, to effectively combat the disease with very good clinical tolerance. This disease has also forced us to review the characteristics of smallpox vaccines, because they have shown a protective effect against monkeypox. For this reason, it is important to have a document that compiles all the scientific information published in this regard.(AU)


Subject(s)
Humans , Male , Female , Zoonoses/microbiology , Mpox (monkeypox)/drug therapy , Mpox (monkeypox)/immunology , Antiviral Agents , Vaccines , Cidofovir , Communicable Diseases , Microbiology , Microbiological Techniques , Mpox (monkeypox)/prevention & control
10.
Comput Methods Programs Biomed ; 242: 107844, 2023 Dec.
Article in English | MEDLINE | ID: mdl-37852144

ABSTRACT

BACKGROUND AND OBJECTIVE: This study considers dynamic modeling of the cerebral arterial circulation and reconstructing an atlas for the electrical conductivity of the brain. Electrical conductivity is a governing parameter in several electrophysiological modalities applied in neuroscience, such as electroencephalography (EEG), transcranial electrical stimulation (tES), and electrical impedance tomography (EIT). While high-resolution 7-Tesla (T) Magnetic Resonance Imaging (MRI) data allow for reconstructing the cerebral arteries with a cross-sectional diameter larger than the voxel size, electrical conductivity cannot be directly inferred from MRI data. Brain models of electrophysiology typically associate each brain tissue compartment with a constant electrical conductivity, omitting any dynamic effects of cerebral blood circulation. Incorporating those effects poses the challenge of solving a system of incompressible Navier-Stokes equations (NSEs) in a realistic multi-compartment head model. However, using a simplified circulation model is well-motivated since, on the one hand, the complete system does not always have a numerically stable solution and, on the other hand, the full set of arteries cannot be perfectly reconstructed from the MRI data, meaning that any solution will be approximative. METHODS: We postulate that circulation in the distinguishable arteries can be estimated via the pressure-Poisson equation (PPE), which is coupled with Fick's law of diffusion for microcirculation. To establish a fluid exchange model between arteries and microarteries, a boundary condition derived from the Hagen-Poisseuille model is applied. The relationship between the estimated volumetric blood concentration and the electrical conductivity of the brain tissue is approximated through Archie's law for fluid flow in porous media. RESULTS: Through the formulation of the PPE and a set of boundary conditions (BCs) based on the Hagen-Poisseuille model, we obtained an equivalent formulation of the incompressible Stokes equation (SE). Thus, allowing effective blood pressure estimation in cerebral arteries segmented from open 7T MRI data. CONCLUSIONS: As a result of this research, we developed and built a useful modeling framework that accounts for the effects of dynamic blood flow on a novel MRI-based electrical conductivity atlas. The electrical conductivity perturbation obtained in numerical experiments has an appropriate overall match with previous studies on this subject. Further research to validate these results will be necessary.


Subject(s)
Brain , Head , Brain/diagnostic imaging , Brain/physiology , Electric Conductivity , Computer Simulation , Cerebral Arteries/diagnostic imaging
11.
PLoS One ; 18(9): e0290715, 2023.
Article in English | MEDLINE | ID: mdl-37729152

ABSTRACT

This paper introduces an automated approach for generating a finite element (FE) discretization of a multi-compartment human head model for electroencephalographic (EEG) source localization. We aim to provide an adaptable FE mesh generation tool for EEG studies. Our technique relies on recursive solid angle labeling of a surface segmentation coupled with smoothing, refinement, inflation, and optimization procedures to enhance the mesh quality. In this study, we performed numerical meshing experiments with the three-layer Ary sphere and a magnetic resonance imaging (MRI)-based multi-compartment head segmentation which incorporates a comprehensive set of subcortical brain structures. These experiments are motivated, on one hand, by the sensitivity of non-invasive subcortical source localization to modeling errors and, on the other hand, by the present lack of open EEG software pipelines to discretize all these structures. Our approach was found to successfully produce an unstructured and boundary-fitted tetrahedral mesh with a sub-one-millimeter fitting error, providing the desired accuracy for the three-dimensional anatomical details, EEG lead field matrix, and source localization. The mesh generator applied in this study has been implemented in the open MATLAB-based Zeffiro Interface toolbox for forward and inverse processing in EEG and it allows for graphics processing unit acceleration.


Subject(s)
Electroencephalography , Prostheses and Implants , Humans , Acceleration , Brain , Epidemiological Models
12.
Hum Immunol ; 84(11): 571-577, 2023 Nov.
Article in English | MEDLINE | ID: mdl-37777360

ABSTRACT

BACKGROUND: Immigrants represented 21.8% of cases in a Spanish cohort of hospitalised patients with COVID-19, a proportion exceeding the percentage of immigrants in that area's total population. Among the ethnic-related genetic risk factors for COVID-19, human leukocyte antigen (HLA) genotypes in diverse populations might bias the response to SARS-CoV-2 infection and/or progression. Similarly, genetic differences in natural killer-activating and inhibitory receptors could play a role in the immune system's response to the viral infection. METHODS: We characterised HLA alleles and KIR genes in 52 Ecuadorian patients hospitalised for moderate and severe COVID-19 and 87 Ecuadorian controls from the general population living in the same area. RESULTS: There was a significantly increased frequency of the HLA-B*39 antigen and the activating KIR2DS4 receptor in the presence of its HLA-C*04 ligand in the COVID-19 group when compared with the control group. In contrast, there was a significant reduction in the frequency of carriers of KIR2DL1 and of the KIR3DL1/Bw4 receptor/ligand combination among COVID-19 group. On the other hand, HLA-A*24:02 and HLA-DRB1*09:01 alleles showed significantly lower frequencies specifically in the severe COVID-19 group. CONCLUSION: HLA-B*39 alleles might be genetic risk factors for developing COVID-19 in Ecuadorian individuals. In the presence of its ligand C*04, the natural killer-activating receptor KIR2DS4 might also increase the risk of developing COVID-19, while, in the presence of HLA-Bw4 alleles, the inhibitory receptor KIR3DL1 might play a protective role. Patients with COVID-19 who carry HLA-A*24:02 and HLA-DRB1*09:01 alleles might be protected against more severe forms of COVID-19.


Subject(s)
COVID-19 , Receptors, KIR , Humans , HLA-DRB1 Chains/genetics , Ligands , Protective Factors , Ecuador/epidemiology , Receptors, KIR/genetics , COVID-19/genetics , SARS-CoV-2 , HLA Antigens/genetics , Histocompatibility Antigens Class I/genetics , HLA-B Antigens/genetics , Genotype , HLA-A Antigens/genetics
13.
Phys Rev Lett ; 130(17): 176901, 2023 Apr 28.
Article in English | MEDLINE | ID: mdl-37172240

ABSTRACT

Magnetic 2D materials hold promise to change the miniaturization paradigm of unidirectional photonic components. However, the integration of these materials in devices hinges on the accurate determination of the optical properties down to the monolayer limit, which is still missing. By using hyperspectral wide-field imaging at room temperature, we reveal a nonmonotonic thickness dependence of the complex optical dielectric function in the archetypal magnetic 2D material CrI_{3} extending across different length scales: onsetting at the mesoscale, peaking at the nanoscale, and decreasing again down to the single layer. These results portray a modification of the electronic properties of the material and align with the layer-dependent magnetism in CrI_{3}, shedding light on the long-standing structural conundrum in this material. The unique modulation of the complex dielectric function from the monolayer up to more than 100 layers will be instrumental for understanding mesoscopic effects in layered materials and tuning light-matter interactions in magnetic 2D materials.

14.
J Travel Med ; 30(3)2023 05 18.
Article in English | MEDLINE | ID: mdl-37043288

ABSTRACT

BACKGROUND: Rickettsioses are emerging zoonotic diseases with worldwide prevalence, recognized as a cause of imported fever in travellers and migrants. Our objective is to describe the microbiological, clinical and epidemiological characteristics of imported rickettsioses in travellers and migrants included in a Spanish collaborative network database. METHODS: This multicentre retrospective observational study was nested in +Redivi, the Cooperative Network for the Study of Infections Imported by Immigrants and Travellers. We asked collaborating centres for microbiological, clinical and epidemiological data on the rickettsiosis cases from the inception of the network in 2009 to December 2020. RESULTS: Fifty-four cases of imported rickettsioses were included; 35 (64.8%) patients were men, and the median age was 37 years (interquartile range 26, 51.2). Only 7.4% of patients were travellers visiting friends and relatives, and 5.6% were migrants. The most frequent travel destination (38.9%) was South Africa, and 90.7% engaged in a high-risk activity. Twenty-seven patients (50.0%) started presenting symptoms after their return to Spain. The most frequent symptoms were febrile syndrome (55.6%) and cutaneous manifestations (27.8%). Most diagnoses (63.0%) were confirmed by serology. Only a few cases (9.3%) required hospitalization. All participants had a full recovery. CONCLUSIONS: Clinicians should suspect rickettsial diseases in travellers coming from high-risk areas, especially Southern Africa, who have engaged in activities in rural areas and natural parks. Doxycycline should be considered in the empiric treatment of imported fever of travellers coming from those areas or who have engaged in high-risk activities. There is a need to improve access to molecular diagnosis of rickettsiosis in Spain.


Subject(s)
Rickettsia Infections , Transients and Migrants , Male , Animals , Humans , Adult , Female , Spain/epidemiology , Rickettsia Infections/diagnosis , Retrospective Studies , Zoonoses , Travel
15.
Rev. argent. salud publica ; 15: 1-8, 16 Febrero 2023.
Article in Spanish | LILACS, ARGMSAL, BINACIS | ID: biblio-1437137

ABSTRACT

INTRODUCCIÓN: El empleo es uno de los componentes centrales de la recuperación en personas con trastornos mentales severos y un aspecto clave en la validación social. El objetivo del estudio fue conocer la experiencia laboral, el interés por trabajar, las conductas específicas de búsqueda laboral, el estatus ocupacional y las actitudes frente al trabajo en esta población. MÉTODOS: Un total de 103 personas en tratamiento en una institución de salud mental de la ciudad de Buenos Aires completaron un cuestionario censal en 2018 con preguntas abiertas y cerradas. El análisis fue mixto, con cálculo y comparación de frecuencias según grupos y análisis temático. RESULTADOS: La mayoría de los participantes tenía experiencia laboral, aunque solo el 29% estaba trabajando. El 93% de quienes no trabajaban dijo tener interés en hacerlo. Solo un 33% de quienes no tenían trabajo realizaban actividades para conseguirlo. Un 85% consideró que podría tener problemas en caso de trabajar y el 15% señaló que podría hacerle mal. No se observaron diferencias significativas según diagnóstico o género. DISCUSIÓN: El elevado interés por trabajar de las personas con trastornos mentales severos contrasta con un porcentaje considerable que, pese a ello, no busca trabajo y anticipa dificultades laborales. El estigma podría ser uno de los mayores obstáculos para la búsqueda y la inclusión laboral. Los programas de apoyo al empleo deben considerar algunos de los problemas hallados en este estudio.


Subject(s)
Unemployment , Employment , Mental Health Recovery , Mental Disorders
16.
Enferm Infecc Microbiol Clin (Engl Ed) ; 41(10): 629-634, 2023 Dec.
Article in English | MEDLINE | ID: mdl-36624034

ABSTRACT

Monkeypox is a zoonosis that is spread mainly through direct contact with fluids and skin lesions of infected people with vesicles still active. Although the virus was isolated for the first time in 1958 and the first human case was identified in a child in 1970, in the Democratic Republic of the Congo, the disease has progressively increased its incidence in Africa reaching in May 2022 sustained transmission outside this continent. As it is a newly introduced virus in our health system, it is necessary to learn the epidemiological pattern in a different environment from that of traditionally endemic areas and to know the available antiviral treatments, as well as the prophylactic measures that could be considered, knowing that as a virus emerging in our regions, scientific evidence is still limited. There are antivirals that have been shown, in animal models, to effectively combat the disease with very good clinical tolerance. This disease has also forced us to review the characteristics of smallpox vaccines, because they have shown a protective effect against monkeypox. For this reason, it is important to have a document that compiles all the scientific information published in this regard.


Subject(s)
Mpox (monkeypox) , Smallpox Vaccine , Child , Animals , Humans , Mpox (monkeypox)/drug therapy , Mpox (monkeypox)/epidemiology , Mpox (monkeypox)/prevention & control , Monkeypox virus , Smallpox Vaccine/therapeutic use , Africa , Incidence
17.
Clin Infect Dis ; 76(3): e116-e125, 2023 02 08.
Article in English | MEDLINE | ID: mdl-35906838

ABSTRACT

BACKGROUND: This study was designed to evaluate if patients with high risk for severe coronavirus disease 2019 (COVID-19) would benefit from treatment with tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) followed by baricitinib in case of hypoxemia and systemic inflammation. METHODS: PANCOVID is an open-label, double-randomized, phase 3 pragmatic clinical trial including adults with symptomatic COVID-19 with ≥2 comorbidities or aged ≥60 years and was conducted between 10 October 2020 and 23 September 2021. In the first randomization, patients received TDF/FTC or no TDF/FTC. In the second randomization, patients with room air oxygen saturation <95% and at least 1 increased inflammatory biomarker received baricitinib plus dexamethasone or dexamethasone alone. The primary endpoint was 28-day mortality. Main secondary endpoint was 28-day disease progression or critical care unit admission or mortality. The trial was stopped before reaching planned sample size due to the decrease in the number of cases and a mortality rate substantially lower than expected. RESULTS: Of the 355 included participants, 97% were hospitalized at baseline. Overall, 28-day mortality was 3.1%. The 28-day mortality relative risk (RR) for participants treated with TDF/FTC was 1.76 (95% confidence interval [CI], .52-5.91; P = .379); it was 0.42 (95% CI, .11-1.59; P = .201) for those treated with baricitinib. The 28-day RR for the main secondary combined endpoint for participants treated with TDF/FTC was 0.95 (95% CI, .66-1.40; P = .774); it was 0.90 (95% CI, .61-1.33; P = .687) for those treated with baricitinib. CONCLUSIONS: Our results do not suggest a beneficial effect of TDF/FTC; nevertheless, they are compatible with the beneficial effect of baricitinib already established by other clinical trials. CLINICAL TRIALS REGISTRATION: EudraCT: 2020-001156-18.


Subject(s)
Anti-HIV Agents , COVID-19 , HIV Infections , Adult , Humans , Tenofovir/therapeutic use , Emtricitabine/therapeutic use , Anti-HIV Agents/therapeutic use , HIV Infections/drug therapy , COVID-19 Drug Treatment , Dexamethasone
18.
Article in Spanish | MEDLINE | ID: mdl-36249471

ABSTRACT

Monkeypox is a zoonosis that is spread mainly through direct contact with fluids and skin lesions of infected people with vesicles still active. Although the virus was isolated for the first time in 1958 and the first human case was identified in a child in 1970, in the Democratic Republic of the Congo, the disease has progressively increased its incidence in Africa reaching in May 2022 sustained transmission outside this continent. As it is a newly introduced virus in our health system, it is necessary to learn the epidemiological pattern in a different environment from that of traditionally endemic areas and to know the available antiviral treatments, as well as the prophylactic measures that could be considered, knowing that as a virus emerging in our regions, scientific evidence is still limited. There are antivirals that have been shown, in animal models, to effectively combat the disease with very good clinical tolerance. This disease has also forced us to review the characteristics of smallpox vaccines, because they have shown a protective effect against monkeypox. For this reason, it is important to have a document that compiles all the scientific information published in this regard.

19.
Comput Methods Programs Biomed ; 226: 107084, 2022 Nov.
Article in English | MEDLINE | ID: mdl-36099674

ABSTRACT

BACKGROUND AND OBJECTIVE: This study focuses on Multi-Channel Transcranial Electrical Stimulation, a non-invasive brain method for stimulating neuronal activity under the influence of low-intensity currents. We introduce a mathematical formulation for finding a current pattern that optimizes an L1-norm fit between a given focal target distribution and volumetric current density inside the brain. L1-norm is well-known to favor well-localized or sparse distributions compared to L2-norm (least-squares) fitted estimates. METHODS: We present a linear programming approach that performs L1-norm fitting and penalization of the current pattern (L1L1) to control the number of non-zero currents. The optimizer filters a large set of candidate solutions using a two-stage metaheuristic search from a pre-filtered set of candidates. RESULTS: The numerical simulation results obtained with both 8- and 20-channel electrode montages suggest that our hypothesis on the benefits of L1-norm data fitting is valid. Compared to an L1-norm regularized L2-norm fitting (L1L2) via semidefinite programming and weighted Tikhonov least-squares method (TLS), the L1L1 results were overall preferable for maximizing the focused current density at the target position, and the ratio between focused and nuisance current magnitudes. CONCLUSIONS: We propose the metaheuristic L1L1 optimization approach as a potential technique to obtain a well-localized stimulus with a controllable magnitude at a given target position. L1L1 finds a current pattern with a steep contrast between the anodal and cathodal electrodes while suppressing the nuisance currents in the brain, hence, providing a potential alternative to modulate the effects of the stimulation, e.g., the sensation experienced by the subject.


Subject(s)
Least-Squares Analysis , Computer Simulation , Electrodes
20.
Rev. patol. respir ; 25(3): 79-84, Jul-Sep. 2022. graf, tab
Article in English | IBECS | ID: ibc-211659

ABSTRACT

Objetive: To describe the incidence and features of incidental pulmonary embolism (IPE) and survival of all patients with IPE from January 2012 to December 2014. Rationale: The prevalence of IPE accounts for 1–10% of all pulmonary embolisms (PE). Methods: All radiological reports of computed tomography with intravenous contrast in which the IPE was not suspected were evaluated. The numerical data are expressed by mean and standard deviation (SD); Survival by the Kaplan–Meier analysis and the Log Rank test. Results: We reviewed 7508 reports, detecting 44 patients with IPE (0.6%). Men 64%, age 68 years, pack-year 25, oncological disease 73%, chemotherapy last month before IPE 82%. The predominant histological strain was adenocarcinoma (60%) and epidermoid (20%). The origin of the most common tumor was bronchogenic (27%) and colorectal (14%). The distribution according to the PESI index was mainly I (71%) and II (21%). They received anticoagulation 54%. The location of thrombi was bilateral in 32%. Around 70% were located in main and lobar arteries. Overall survival at one year was more than 70%, being higher in anticoagulated patients (log rank <0.05). Conclusions: The incidence of IPE is low, predominantly in oncological patients. Adenocarcinoma is the predominant strain. Most of them have a low severity index. Survival is higher in anticoagulated patients and higher than in the case of published non-incidental PE.(AU)


Objetivo: Describir la incidencia, características y supervivencia de todos los pacientes con TEPI desde Enero de 2012 hasta Diciembre de 2014. Justificación: La prevalencia de tromboembolismo pulmonar incidental (TEPI) ocurre en el 1–10% de todos los tromboembolismos pulmonares (TEP). Método: Todos los informes radiológicos de tomografía computerizada con contraste intravenoso en los cuales el TEP no era sospechado fueron evaluados. Los resultados numéricos fueron expresados mediante media y desviación estándar; Supervivencia por KaplanMeier y test de LogRank. Resultado: Revisamos 7508 informes detectando 44 pacientes con TEPI (0.6%). Hombres 64%, edad 68 años, índice paquetes-año 25, enfermedad oncológica 73%, quimioterapia el mes previo al TEPI 82%. La estirpe histológica predominante fue adenocarcinoma (60%) y epidermoide (20%). El origen del tumor más frecuente fue broncogénico (27%) y colorrectal (14%). La distribución teniendo en cuenta la escala PESI fue predominantemente I (71%) y II (21%). Recibieron anticoagulación el 54%. La localización del trombo fue bilateral en el 32%. En torno al 70% fueron localizados en arterias principales y lobares. La supervivencia global al año fue mayor del 70%, siendo mayor en pacientes anticoagulados (log rank <0.05). Conclusiones: La incidencia de TEPI es baja, predominantemente en pacientes oncológicos. La mayoría presentaron bajo índice de severidad. La supervivencia es mayor en pacientes anticoagulados y mayor que la publicada para embolismos pulmonares no incidentales.(AU)


Subject(s)
Humans , Male , Female , Aged , Pulmonary Embolism , Incidence , Survivorship , Neoplasms , Anticoagulants , Respiratory Tract Diseases
SELECTION OF CITATIONS
SEARCH DETAIL
...